Home > PJ (current issue) > News / Daily News | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 271 No 7278 p768
6 December 2003

This article
Reprint
Photocopy


News summary


Updated HRT prescribing advice

Hormone replacement therapy should no longer be recommended as first choice therapy for prevention of osteoporosis, according to new advice from the Medicines and Healthcare products Regulatory Agency.

Full details are available from the MHRA website (www.mhra.gov.uk).

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal